BOT.AX लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 11:40):

Stats
आज की मात्रा	3.27M
औसत मात्रा	2.57M
बाजार मूल्य	346.53M
EPS	$0 ( 2024-02-25 )
अगली कमाई की तारीख	( $0 ) 2024-07-28
Last Dividend	$95.85 ( 1996-10-03 )
Next Dividend	$0 ( N/A )
P/E	-22.00
ATR14	$0.00200 (0.93%)

मात्रा सहसंबंध

लंबा: 0.12 (neutral)

छोटा: 0.22 (neutral)

Signal:(40.465) Neutral

Botanix Pharmaceuticals सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Botanix Pharmaceuticals सहसंबंध - मुद्रा/वस्त्र

0.00
( neutral )

-0.44
( neutral )

Botanix Pharmaceuticals वित्तीय

Annual	2023
राजस्व:	$914 973
सकल लाभ:	$-3.05M (-332.90 %)
EPS:	$-0.00790

FY	2023
राजस्व:	$914 973
सकल लाभ:	$-3.05M (-332.90 %)
EPS:	$-0.00790

FY	2022
राजस्व:	$2.75M
सकल लाभ:	$2.61M (94.79 %)
EPS:	$-0.0135

FY	2021
राजस्व:	$0.00
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-0.00438

Financial Reports:

No articles found.

Botanix Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Botanix Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$81.28	1994-02-18
Last Dividend	$95.85	1996-10-03
Next Dividend	$0	N/A
Payout Date	1996-10-25
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	$510.23	--
Avg. Dividend % Per Year	0.00%	--
Score	1.06	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-11-04)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.06

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
LOV.AX	Ex Dividend Knight	2023-09-12	Annually	0.00%
SXE.AX	Ex Dividend Knight	2023-09-26	Annually	0.00%
CRN.AX	Ex Dividend Knight	2023-08-28	Annually	0.00%
NCC.AX	Ex Dividend Junior	2023-10-04	Semi-Annually	0.00%
WOR.AX	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
EVT.AX	Ex Dividend Knight	2023-09-13	Annually	0.00%
PIA.AX	Ex Dividend Knight	2023-08-31	Quarterly	0.00%
AOF.AX	Ex Dividend Junior	2023-06-29	Quarterly	0.00%
HUB.AX	Ex Dividend Knight	2023-09-11	Semi-Annually	0.00%
RMC.AX	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-11.08	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.210	1.200	-7.01	-8.41	[0 - 0.3]
returnOnEquityTTM	-0.293	1.500	-4.37	-6.56	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	9.50	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	8.09	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	7.99	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	-858.83	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.00702	2.00	-0.00234	-0.00468	[0 - 30]
freeCashFlowPerShareTTM	-0.0186	2.00	-0.00932	-0.0186	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	-5.76	1.000	-10.00	-10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-11.10	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.0190	0.800	-3.21	-2.57	[0.5 - 2]
Total Score				-3.67

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-31.58	1.000	-3.29	0	[1 - 100]
returnOnEquityTTM	-0.293	2.50	-2.81	-6.56	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0186	2.00	-0.00621	-0.0186	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.00702	2.00	-0.00234	-0.00468	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.106	1.500	-2.62	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-11.17	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.43

Botanix Pharmaceuticals

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.